https://www.sigyntherapeutics.com/investors/news-events/press-releases/rss Please specify a description for this RSS Feed en-us https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/118/sigyn-therapeutics-issues-shareholder-update-highlighting Thu, 15 Jan 26 10:52:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/118/sigyn-therapeutics-issues-shareholder-update-highlighting https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/117/the-emergence-of-blood-purification-devices-to-treat Tue, 06 Jan 26 17:01:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/117/the-emergence-of-blood-purification-devices-to-treat https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/116/sigyn-ceo-note-first-in-industry-attributes-of Thu, 11 Dec 25 11:38:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/116/sigyn-ceo-note-first-in-industry-attributes-of https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/115/sigyn-ceo-note-nature-publication-reinforces-rationale-for Wed, 03 Dec 25 07:51:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/115/sigyn-ceo-note-nature-publication-reinforces-rationale-for https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/114/sigyn-cardiodialysistm-featured-on-the-big-biz-show Tue, 18 Nov 25 07:51:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/114/sigyn-cardiodialysistm-featured-on-the-big-biz-show https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/113/sigyn-therapeutics-reports-third-quarter-financial-results Fri, 14 Nov 25 17:07:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/113/sigyn-therapeutics-reports-third-quarter-financial-results https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/112/sigyn-therapeutics-releases-shareholder-letter-to-introduce Thu, 06 Nov 25 10:44:00 -0500 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/112/sigyn-therapeutics-releases-shareholder-letter-to-introduce https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/110/sigyn-therapeutics-inc-to-present-at-the-ld-micro-main Tue, 21 Oct 25 12:31:00 -0400 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/110/sigyn-therapeutics-inc-to-present-at-the-ld-micro-main https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/109/sigyn-therapeutics-appoints-dr-christoph-zaba-to-its Thu, 11 Sep 25 07:58:00 -0400 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/109/sigyn-therapeutics-appoints-dr-christoph-zaba-to-its https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/108/sigyn-therapeutics-announces-cardiovascular-disease-study Wed, 03 Sep 25 07:12:00 -0400 https://www.sigyntherapeutics.com/investors/news-events/press-releases/detail/108/sigyn-therapeutics-announces-cardiovascular-disease-study